Skip to Content

Non-Coding RNA, Volume 7, Issue 1

2021 March - 23 articles

Cover Story: In silico predictions and interactions must be considered pivotal starting points to screen and design novel drugs to counter SARS-CoV-2-induced inflammatory complications. Indeed, we identified selective motifs in the leader sequence of the SARS-CoV-2 genome as promising sites to generate antiviral selective drugs. Notably, major effective mutations currently reported for SARS-CoV-2 variants involve coding regions, whereas reliable mutations in the leader sequence and correlations with the severity of COVID-19 disease are missing. We identified target motifs in the leader sequence suitable for specific bindings with endogenous human miRNAs and lncRNAs that can be therefore considered a conceptual background for the development of RNA-based drugs against COVID-19. View this paper.
  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
  • You may sign up for email alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.

Articles

There are no articles in this issue yet.
XFacebookLinkedIn
Non-Coding RNA - ISSN 2311-553X